Cancer-specific and overall survival in African American women with endometrial cancer: a SEER-Medicare study

2021 ◽  
Vol 162 ◽  
pp. S102
Author(s):  
Daniel Saris ◽  
Anna Jo Smith ◽  
Colleen Brensinger ◽  
Sarah Kim ◽  
Ashley Haggerty ◽  
...  
2003 ◽  
Vol 21 (22) ◽  
pp. 4200-4206 ◽  
Author(s):  
Thomas C. Randall ◽  
Katrina Armstrong

Purpose: To investigate disparities in treatment and outcomes between African-American and white women with endometrial cancer. Patients and Methods: We analyzed 1992 to 1998 Surveillance, Epidemiology, and End Results data for 21,561 women with epithelial cancers of the endometrium. Sequential Cox proportional hazard models were used to determine the association between tumor characteristics (stage, grade, and histologic type), sociodemographic characteristics (age and marital status), and treatment (surgery and radiation therapy) and the racial difference in mortality. Results: The unadjusted hazard ratio (HR) for death from endometrial cancer for African-American women compared with white women was 2.57. However, African-American women were significantly more likely to present with advanced-stage disease and have poorly differentiated tumors or tumors with an unfavorable histologic type and were significantly less likely to undergo definitive surgery at all stages of disease. Adjusting for tumor and sociodemographic characteristics lowered the HR for African-American women to 1.80. Further adjustment for the use of surgery reduced the HR to 1.51. The association between surgery and survival was stronger among white women (HR, 0.26) than among African-American women (HR, 0.44). Conclusion: African-American women with endometrial cancer are significantly less likely to undergo primary surgery and have significantly shorter survival than white women with endometrial cancer. Racial differences in treatment are associated with racial differences in survival. The association between use of surgery and survival is weaker among African-American than white women, raising questions about potential racial differences in the effectiveness of surgery.


2012 ◽  
Vol 31 (1) ◽  
pp. 66-72 ◽  
Author(s):  
Michele L. Cote ◽  
Audrey Kam ◽  
Cherry Yin-Yi Chang ◽  
Leon Raskin ◽  
Kerryn W. Reding ◽  
...  

2016 ◽  
Author(s):  
Danielle Daley-Brown ◽  
Gabriela Oprea-Ilies ◽  
Regina Lee ◽  
Kiara T. Vann ◽  
Viola Lanier ◽  
...  

2012 ◽  
Vol 22 (8) ◽  
pp. 1367-1372 ◽  
Author(s):  
Michele L. Cote ◽  
Govindaraja Atikukke ◽  
Julie J. Ruterbusch ◽  
Sara H. Olson ◽  
Shawnita Sealy-Jefferson ◽  
...  

ObjectiveTo describe the pattern and frequency of oncogene mutations in white and African American women with endometrial cancer and to determine if racial differences in oncogene mutations exist among women with pathologically similar tumors.MethodsPatients with endometrial cancer from a large urban hospital were identified through medical records, and representative formalin-fixed paraffin-embedded tumor blocks were retrieved. The study sample included 150 patients (84 African Americans) who underwent total abdominal hysterectomy for endometrial cancer. The Sequenom MassARRAY system and the OncoCarta Assay version 1.0 (Sequenom) were used to test for 238 mutations in 19 common oncogenes. The χ2test and the Fisher exact test were used to assess differences in distribution of variables by race and oncogene mutation status.ResultsThere were 20 mutations identified in 2 oncogenes (PIK3CAandKRAS) in tumors from 19 women (12.7%). Most of the mutations were found inPIK3CA(16/20). Thirteen percent of endometrioid tumors harbored mutations (11PIK3CAand 2KRAS) as did 29% of the malignant mixed Mullerian tumors (3PIK3CAand 1KRAS). There were no observed mutations in serous, clear cell, or mucinous tumor types. Among low-grade endometrioid cancers, tumors from African American patients were significantly associated with harboring either aKRASorPIK3CAmutation (P= 0.04), with 7PIK3CAmutations and all 4KRASmutations identified in African American women.ConclusionsThis study provides preliminary evidence that oncogene mutation frequency of some subtypes of histologically similar endometrial carcinoma differ by race. Additional studies are needed to further explore this phenomenon in patients with endometrial carcinoma.


Sign in / Sign up

Export Citation Format

Share Document